Clinical trials
Phase 2 Cutaneous Squamous Cell Carcinoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 6 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 3 |
| Massachusetts General Hospital | 2 |
| Regeneron Pharmaceuticals | 2 |
| Stanford University | 2 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Karam Khaddour, MD, MS | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cutaneous Squamous Cell Carcinoma | 20 |
| Skin Neoplasms | 9 |
| Carcinoma, Squamous Cell | 5 |
| Keratosis, Actinic | 3 |
| Neoplasm Metastasis | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Basal Cell Carcinoma | 2 |
| Carcinoma, Merkel Cell | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.